|
Thewallstreetleader.com: TheWallStreetLeader.com: Stock News Updates:
ARIN & AMGN
(M2 PressWIRE Via Acquire Media NewsEdge)
RDATE:01102008
Boston, MA -- Airspan Networks Inc. (NASDAQ: AIRN); Amgen Inc.,
(NASDAQ: AMGN)
TheWallStreetLeader.com is part of Stock Profiler.US, LLC's News
Division. Stock Profiler welcomes investors to chat LIVE about these
stocks and more on their upgraded website with FREE Investor Tools,
Live Chats, and much more! Sign up now at www.stockprofiler.us.
Companies who want to broadcast their message are encouraged to contact
Stock Profiler.US, LLC at (603) 424-4420.
-------------------------------------------
Airspan Networks Inc. (NASDAQ: AIRN) closed at $0.34 Tuesday, trading
60,600 shares.
Company News- September 30, 2008: One Communications Kenya Selects
Airspan's WiMAX Infrastructure
Airspan Networks Inc. (NASDAQ: AIRN), a leading provider of WiMAX-based
broadband wireless access networks, announced yesterday that it has
been selected by One Communications (OneCom), a newly-acquired
subsidiary of Safaricom, as their WiMAX infrastructure partner in
OneCom's roll out of a nationwide WiMAX network across Kenya.
To read the full news release, go to www.stockprofiler.us, and click
the Headline link after entering the ticker symbol.
About OneCom
OneCom was incorporated in 2006, and its subsidiaries provide various
data communication services in Nairobi, Kenya. Safaricom acquired a 51
percent stake in the company in August following implementation of
Kenya's unified licensing regime.
About Airspan Networks Inc.
Airspan is the industry's leading WiMAX pure player, ranked #1 for
IEEE802.16-2004 WiMAX revenue in 2007 and has now been selected for
some of the world's largest mobile WiMAX deployments. With direct sales
offices throughout Asia, EMEA and the Americas, a worldwide network of
resellers and agents, and partnership alliances with major OEMs,
Airspan boasts over 100 commercial WiMAX deployments worldwide.
www.airspan.com.
-------------------------------------------
Amgen Inc., (NASDAQ: AMGN) closed at $59.27 Tuesday, trading 14,370,400
shares.
Company News- September 30, 2008: Amgen Receives Executive Summary from
Independent Cochrane Collaboration Review of ESAs in Oncology
Yesterday Amgen Inc., (NASDAQ: AMGN) announced it has received a
summary of preliminary results from the Cochrane Collaboration's
independent meta-analysis of patient-level data from previously
conducted, randomized, controlled, clinical studies evaluating
erythropoiesis-stimulating agents (ESAs) in cancer patients. Amgen has
submitted the executive summary to regulatory authorities, including
the U.S. Food and Drug Administration (FDA) and the European Medicines
Agency (EMEA).
To read the full news release, go to www.stockprofiler.us, and click
the Headline link after entering the ticker symbol.
About The Cochrane Collaboration
The Cochrane Collaboration is an international not-for-profit and
independent organization, dedicated to making up-to-date, accurate
information about the effects of healthcare readily available
worldwide. It produces and disseminates systematic reviews of
healthcare interventions and promotes the search for evidence in the
form of clinical trials and other studies of interventions.
About Amgen
Amgen discovers, develops, manufactures and delivers innovative human
therapeutics. A biotechnology pioneer since 1980, Amgen was one of the
first companies to realize the new science's promise by bringing safe
and effective medicines from lab, to manufacturing plant, to patient.
Amgen therapeutics have changed the practice of medicine, helping
millions of people around the world in the fight against cancer, kidney
disease, rheumatoid arthritis and other serious illnesses. With a deep
and broad pipeline of potential new medicines, Amgen remains committed
to advancing science to dramatically improve people's lives. To learn
more about our pioneering science and our vital medicines, visit
www.amgen.com.
-------------------------------------------
The companies that are discussed in this opinion have not approved the
statements made in this opinion. This opinion contains forward-looking
statements that involve risks and uncertainties. This material is for
informational purposes only and should not be construed as an offer or
solicitation of an offer to buy or sell securities.
TheWallStreetLeader.com is a division of Stock Profiler.US, LLC's News
Division, which includes but is not limited to www.stockprofiler.us,
www.businessnetwire.us, www.financialbusinessnews.us,
www.fastmoneytalk.com, www.markettelegraph.com,
www.associatesfortune.com and www.daytradersdigest.com. Stock
Profiler.US, LLC has been compensated for services rendered; Stock
Profiler.US, LLC is not a licensed broker, broker dealer, market maker,
investment banker, investment advisor, analyst or underwriter.
Please consult a broker before purchasing or selling any securities
mentioned herein. To view full disclaimers and terms of use, go to
www.stockprofiler.us.
Keywords: Small Cap Investments, Investor Relations, I/R Services,
Investment Tools, Stock Profiles, Stock Market Quotes News, Media
Coverage
CONTACT: Thewallstreetleader.com
Tel: +1 603 424 4420
e-mail: info@ stockprofiler.us
WWW: http://www.thewallstreetleader.com
((M2 Communications Ltd disclaims all liability for information
provided within M2 PressWIRE. Data supplied by named party/parties.
Further information on M2 PressWIRE can be obtained at
http://www.presswire.net on the world wide web. Inquiries to
info@m2.com)).
Copyright ? 2008 M2 Communications Ltd.
[ Back To TMCnet.com's Homepage ]
|
INDUSTRIES
Activate Email 
Find Solutions for Enterprises, SMBs & Service Providers at the INTERNET TELEPHONY Conference and EXPO East, January 20-22, 2010. Miami, FL.
